11-108244065-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_000051.4(ATM):​c.609C>T​(p.Asp203Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,613,592 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 2 hom. )

Consequence

ATM
NM_000051.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:20

Conservation

PhyloP100: 2.03

Publications

8 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 11-108244065-C-T is Benign according to our data. Variant chr11-108244065-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135764.
BP7
Synonymous conserved (PhyloP=2.03 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00164 (249/152030) while in subpopulation NFE AF = 0.00253 (172/67994). AF 95% confidence interval is 0.00222. There are 1 homozygotes in GnomAd4. There are 118 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.609C>Tp.Asp203Asp
synonymous
Exon 6 of 63NP_000042.3
ATM
NM_001351834.2
c.609C>Tp.Asp203Asp
synonymous
Exon 7 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.609C>Tp.Asp203Asp
synonymous
Exon 6 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.609C>Tp.Asp203Asp
synonymous
Exon 7 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.609C>Tp.Asp203Asp
synonymous
Exon 6 of 30ENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
249
AN:
151914
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00114
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00253
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00147
AC:
368
AN:
251168
AF XY:
0.00152
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00143
Gnomad NFE exome
AF:
0.00234
Gnomad OTH exome
AF:
0.00164
GnomAD4 exome
AF:
0.00193
AC:
2823
AN:
1461562
Hom.:
2
Cov.:
34
AF XY:
0.00196
AC XY:
1425
AN XY:
727078
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33466
American (AMR)
AF:
0.000895
AC:
40
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.000459
AC:
12
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39620
South Asian (SAS)
AF:
0.000429
AC:
37
AN:
86252
European-Finnish (FIN)
AF:
0.00144
AC:
77
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00225
AC:
2502
AN:
1111864
Other (OTH)
AF:
0.00237
AC:
143
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
150
300
451
601
751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
249
AN:
152030
Hom.:
1
Cov.:
32
AF XY:
0.00159
AC XY:
118
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.000482
AC:
20
AN:
41470
American (AMR)
AF:
0.00223
AC:
34
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00114
AC:
12
AN:
10510
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00253
AC:
172
AN:
67994
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00168
Hom.:
0
Bravo
AF:
0.00138
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00175
EpiControl
AF:
0.00202

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
5
not provided (5)
-
1
3
Ataxia-telangiectasia syndrome (4)
-
-
4
not specified (4)
-
-
2
Familial cancer of breast (2)
-
-
1
Breast and/or ovarian cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
8.8
DANN
Benign
0.45
PhyloP100
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144709948; hg19: chr11-108114792; COSMIC: COSV53765648; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.